Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT04602013 · UNKNOWN
Trial details
- NCT number
- NCT04602013
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-11
- Primary completion
- 2022-05-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.